Showing results (321-330 of 341) with videos related to
Sort By:
Pageof 35
Bioorganic & Medicinal Chemistry Letters|February 6, 2007
A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitorsXiao-Tao Chen, Bahman Ghavimi, Ronald L Corbett, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 8, 2016
Arterial ischemic stroke in HIV: Defining and classifying etiology for research studiesLaura A Benjamin, Alan Bryer, Sebastian Lucas, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2022
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary TuberculosisAndrew D McCallum, Henry E Pertinez, Aaron P Chirambo, et al.Journal of Medicinal Chemistry|April 22, 2010
Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)Nancy-Ellen Haynes, Wendy L Corbett, Fred T Bizzarro, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 DiabetesYimin Qian, Wendy L Corbett, Steven J Berthel, et al.BMC Public Health|November 8, 2018
The effectiveness and cost-effectiveness of community-based lay distribution of HIV self-tests in increasing uptake of HIV testing among adults in rural Malawi and rural and peri-urban Zambia: protocol for STAR (self-testing for Africa) cluster randomized evaluationsMelissa Neuman, Pitchaya Indravudh, Richard Chilongosi, et al.The Lancet. Global Health|January 27, 2019
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling studyKrishna P Reddy, Ankur Gupta-Wright, Katherine L Fielding, et al.Eclinicalmedicine|October 4, 2021
Does tuberculosis screening improve individual outcomes? A systematic reviewL Telisinghe, M Ruperez, M Amofa-Sekyi, et al.PLOS Global Public Health|October 8, 2025
Provider costs of professional COVID-19 rapid antigen testing in low-income settingsCollin Mangenah, Lucky G Ngwira, Obinna Ekwunife, et al.Science (New York, N.Y.)|July 19, 2003
Allosteric activators of glucokinase: potential role in diabetes therapyJoseph Grimsby, Ramakanth Sarabu, Wendy L Corbett, et al.Pageof 35